These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9152593)

  • 1. Kinetics of hepatic accumulation of dextrans in isolated perfused rat livers.
    Mehvar R
    Drug Metab Dispos; 1997 May; 25(5):552-6. PubMed ID: 9152593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of fluorescein-labelled dextran (150 kD) in isolated perfused livers from control and diabetic rats.
    Mehvar R; Reynolds JM; Shepard TL
    Life Sci; 1991; 49(23):1699-706. PubMed ID: 1719328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 70-kilodalton fluorescein-dextran in experimental diabetes mellitus.
    Mehvar R; Reynolds JM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):662-9. PubMed ID: 7679734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice.
    Kaneo Y; Uemura T; Tanaka T; Kanoh S
    Biol Pharm Bull; 1997 Feb; 20(2):181-7. PubMed ID: 9057983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats.
    Mehvar R; Robinson MA; Reynolds JM
    J Pharm Sci; 1994 Oct; 83(10):1495-9. PubMed ID: 7533835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of changes in hepatic disposition of phenolsulfonphthalein, indocyanine green and fluorescein isothiocyanate-dextran at low temperatures using a rat liver perfusion system.
    Miyamoto H; Miyake H; Yoshikawa N; Hirata H; Ohwaki Y; Fumoto S; Sasaki H; Nakamura J; Nishida K
    J Pharm Pharmacol; 2012 Jun; 64(6):848-54. PubMed ID: 22571263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption characteristics of dextrans with different molecular weights from the liver surface membrane in rats: implications for targeting to the liver.
    Nishida K; Sato N; Sasaki H; Nakamura J
    J Drug Target; 1996; 4(3):141-50. PubMed ID: 8959486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic disposition of cyclosporine A in isolated perfused rat livers.
    Mehvar R; Chimalakonda AP
    J Pharm Pharm Sci; 2004 Feb; 7(1):47-54. PubMed ID: 15144734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of fluorescein isothiocyanate-dextran transport in the microcirculation of the isolated perfused rat liver.
    Stock RJ; Cilento EV; McCuskey RS
    Hepatology; 1989 Jan; 9(1):75-82. PubMed ID: 2461894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes-induction reduction in the hepatic accumulation of 70-kDA dextran: role of hyperglycemia and hypoinsulinemia.
    Mehvar R; Reynolds J
    J Pharm Sci; 1994 Jul; 83(7):1020-5. PubMed ID: 7525920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependency of the kinetics of dextrans in rats: effects of molecular weight.
    Mehvar R; Robinson MA; Reynolds JM
    J Pharm Sci; 1995 Jul; 84(7):815-8. PubMed ID: 7562429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size-dependent dextran transport across rat alveolar epithelial cell monolayers.
    Matsukawa Y; Lee VH; Crandall ED; Kim KJ
    J Pharm Sci; 1997 Mar; 86(3):305-9. PubMed ID: 9050797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of dimesna to mesna by the isolated perfused rat liver.
    Goren MP; Hsu LC; Li JT
    Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary secretion of fluid-phase markers by the isolated perfused rat liver. Role of transcellular vesicular transport.
    Lake JR; Licko V; Van Dyke RW; Scharschmidt BF
    J Clin Invest; 1985 Aug; 76(2):676-84. PubMed ID: 2411761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers.
    Parasrampuria R; Mehvar R
    Xenobiotica; 2008 Oct; 38(10):1263-73. PubMed ID: 18798123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of storage and homogenization methods on the hepatic recovery of dextrans determined by size-exclusion chromatography.
    Mehvar R
    J Pharm Biomed Anal; 1996 May; 14(7):801-5. PubMed ID: 8809704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
    Onishi H; Imura Y; Uchida M; Machida Y
    Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
    Ito Y; Ise A; Sugioka N; Takada K
    Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculation in periportal and pericentral regions of lobule in perfused rat liver.
    Conway JG; Popp JA; Thurman RG
    Am J Physiol; 1985 Oct; 249(4 Pt 1):G449-56. PubMed ID: 2413767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver.
    Mills CO; Rahman K; Coleman R; Elias E
    Biochim Biophys Acta; 1991 Dec; 1115(2):151-6. PubMed ID: 1764467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.